379 related articles for article (PubMed ID: 17327369)
1. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
2. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
3. Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation.
Chen Y; Biada J; Sood S; Rabkin R
Kidney Int; 2010 Jul; 78(1):89-95. PubMed ID: 20375991
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
[TBL] [Abstract][Full Text] [Related]
5. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ
Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-induced growth hormone resistance in skeletal muscle.
Chen Y; Sood S; Krishnamurthy VM; Rotwein P; Rabkin R
Endocrinology; 2009 Aug; 150(8):3620-6. PubMed ID: 19443577
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
[TBL] [Abstract][Full Text] [Related]
10. Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation.
Hong-Brown LQ; Brown CR; Cooney RN; Frost RA; Lang CH
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E63-72. PubMed ID: 12644450
[TBL] [Abstract][Full Text] [Related]
11. Attenuated expression of episodic growth hormone-induced CYP2C11 in female rats associated with suboptimal activation of the Jak2/Stat5B and other modulating signaling pathways.
Dhir RN; Thangavel C; Shapiro BH
Drug Metab Dispos; 2007 Nov; 35(11):2102-10. PubMed ID: 17682071
[TBL] [Abstract][Full Text] [Related]
12. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone STAT5-mediated signaling and its modulation in mice liver during the growth period.
Martinez CS; Piazza VG; Ratner LD; Matos MN; González L; Rulli SB; Miquet JG; Sotelo AI
Growth Horm IGF Res; 2013; 23(1-2):19-28. PubMed ID: 23245546
[TBL] [Abstract][Full Text] [Related]
15. Impaired growth hormone receptor signaling during non-catch-up growth in rats born small for gestational age.
Huang Y; Du M; Zhuang S; Shen Z; Li Y
Horm Res Paediatr; 2010; 74(2):106-13. PubMed ID: 20395663
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
18. Cardiac resistance to growth hormone in uremia.
Zheng Z; Sun DF; Tummala P; Rabkin R
Kidney Int; 2005 Mar; 67(3):858-66. PubMed ID: 15698425
[TBL] [Abstract][Full Text] [Related]
19. Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.
Ugarte F; Irarrazabal C; Oh J; Dettmar A; Ceballos ML; Rojo A; Ibacache MJ; Suazo C; Lozano M; Delgado I; Cavada G; Azocar M; Delucchi A; Cano F
Pediatr Nephrol; 2016 Jun; 31(6):965-74. PubMed ID: 26747624
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis.
Yumet G; Shumate ML; Bryant P; Lin CM; Lang CH; Cooney RN
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E472-81. PubMed ID: 12169440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
